Leukemia Research
Volume 28, Issue 8 , Pages 785-790, August 2004

The effects of 5-aza-2′-deoxycytidine (Decitabine) on the platelet count in patients with intermediate and high-risk myelodysplastic syndromes

  • Joan van den Bosch

      Affiliations

    • Department of Haematology, Leyenburg Hospital, Leyweg 275, 2545 CH, The Hague, The Netherlands
    • ,
  • Michael Lübbert

      Affiliations

    • Department of Haematology/Oncology, University of Freiburg Medical Centre, Freiburg, Germany
    • ,
  • Gregor Verhoef

      Affiliations

    • Department of Internal Medicine, University Hospital Grootziekengasthuis, Leuven, Belgium
    • ,
  • P.W Wijermans

      Affiliations

    • Department of Haematology, Leyenburg Hospital, Leyweg 275, 2545 CH, The Hague, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31-70-3592556; fax: +31-70-3592209.

Received 11 August 2003; accepted 27 November 2003.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(03)00413-2

doi:10.1016/j.leukres.2003.11.016

Leukemia Research
Volume 28, Issue 8 , Pages 785-790, August 2004

Article Tools

* Image Usage & Resolution